In one paragraphArticle in Cancer science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Zhen LingNational Health Commission Key Laboratory of Glycoconjugate Research, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, China.ORCID https://orcid.org/0009-0001-9831-4846 Yun GuNational Health Commission Key Laboratory of Glycoconjugate Research, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, China.ORCID https://orcid.org/0000-0001-6942-0749 Ziqiu ZhangNational Health Commission Key Laboratory of Glycoconjugate Research, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, China.ORCID https://orcid.org/0009-0007-5637-8415 Jiejie XuNational Health Commission Key Laboratory of Glycoconjugate Research, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, China.ORCID https://orcid.org/0000-0001-7431-9063 Funding
China Postdoctoral Science Foundation 2023M742327Clinical Research Fund of Zhongshan Hospital Fudan University ZSLCYJ202343Development Foundation and Shanghai Municipal Education Commission 25CGA05National Natural Science Foundation of China 82203201National Natural Science Foundation of China 82272786National Natural Science Foundation of China 82303966National Natural Science Foundation of China 82373417National Natural Science Foundation of China 82503945Natural Science Foundation of Fujian Province 2023J05294Natural Science Foundation of Shanghai Municipality 23ZR1409900Shanghai Municipal Health Commission 20254Y0166Shanghai Pujiang Talents Program 24PJD013
6 · The paper itselfAbstract
Indexed as
CD8-Positive T-LymphocytesLymphocytes, Tumor-InfiltratingStomach NeoplasmsAgedChromosomal InstabilityEpstein-Barr Virus InfectionsFemaleHerpesvirus 4, HumanHumansMaleMicrosatellite InstabilityMiddle AgedPrognosisTumor Microenvironmentadjuvant chemotherapyCD8+ T cellgastric cancerimmune microenvironmentTCGA subtype
Identifiers
PMID41863069
PMCPMC13134523
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390